Our commercial advisory committee provides counsel to the organization on key strategic commercial issues related to sales, marketing, pricing, contracting, channel strategy development, new product planning and business development.
Jim Daly has served as Executive Chairman of our Commercial Advisory Committee since February 2016.
Mr. Daly previously served as Executive Vice President and Chief Commercial Officer at Incyte Corporation from 2012 to 2015. Prior to Incyte, Mr. Daly worked for Amgen for 10 years, holding multiple leadership positions. In his last role, Mr. Daly served as Senior Vice President, North America Commercial Operations, Global Marketing and Commercial Development. His teams at Amgen were responsible for the successful commercialization of many biologics, including Neulasta®, Enbrel®, Aranesp®, Vectibix®, Nplate®, Xgeva® and Prolia®. Previously, Mr. Daly spent over 16 years with GlaxoSmithKline, where he held roles of increasing responsibility, including Senior Vice President, General Manager of the Respiratory and Anti-Infective Division, and led the U.S. launch of Advair®. He currently serves on the Boards of Directors of Chimerix, Inc. and Acadia Pharmaceuticals.
Mr. Daly earned both his M.B.A. and B.S. in Pharmacy from the State of University of New York at Buffalo.
